{'fraction_non_alphanumeric': 0.011002444987775062, 'fraction_numerical': 0.0, 'mean_word_length': 5.713114754098361, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Marfan Syndrome: Implications for Athletes and Their Echocardiographic Assessment

Sudden death of competitive athletes is rare. These deaths challenge the perception that trained athletes represent the healthiest segment of modern society. The increasing frequency of such reported deaths worldwide and the visibility of the issue is underlined by the high‐profile nature of each case. The majority of these deaths have been due to a variety of undiagnosed cardiovascular diseases. Marfan syndrome is a heritable disorder of the connective tissue that can hold life threatening consequences, especially for the athletic population. This paper will aim to review cardiovascular pathophysiology and assessment in relation to Marfan syndrome with particular reference to echocardiography and the athletic population.